A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Number of shares, 3 months chart
Year | Volume (Price x Shares) | Change |
---|---|---|
2025 | S$0.33 M | -68.31% |
2024 | S$1.05 M | -33.48% |
2023 | S$1.58 M | -69.53% |
2022 | S$5.19 M | 37.3% |
2021 | S$3.78 M | 22.27% |
2020 | S$3.09 M | -14.77% |
2019 | S$3.63 M | -54.06% |
2018 | S$7.9 M | 134.04% |
2017 | S$3.37 M | -70.94% |
2016 | S$11.63 M | -27.35% |
2015 | S$16 M | 21.11% |
2014 | S$13.21 M | 124.82% |
2013 | S$5.87 M |
Company | FTD volume (3 months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() AbbVie ABBV | S$25.73 M | S$0.20 B | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | S$10.58 M | S$0.12 B | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | S$21.98 M | S$73.33 M | ๐บ๐ธ USA |
![]() Merck MRK | S$12.12 M | S$0.17 B | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | S$11.54 M | S$0.26 B | ๐บ๐ธ USA |
![]() Novartis NVS | S$8.82 M | S$0.15 B | ๐จ๐ญ Switzerland |